IBM Stock Is Up 8 Percent Today And Here's Why

IBM shares climbed approximately 8 percent in Monday's early trading as Barclays initiated coverage on the company with an Overweight rating and a price target of $350 — adding fresh Wall Street validation to a stock that just completed its best calendar month in nearly a quarter century.

IBM surged approximately 30 percent in May 2026, its strongest monthly performance since 2002, driven by a $1 billion federal quantum computing grant, a company commitment to spend $10 billion on quantum over five years and a $5 billion AI-linked open-source software initiative that the company is pursuing with Red Hat under the name Project Lightwell.

Barclays analyst Raimo Lenschow framed the IBM bull case around a specific structural observation: nearly half of the company's revenue and the majority of its profit already come from software, a mix that is expected to grow further as software outpaces IBM's other segments in growth rate.

The $350 target implies approximately 17.5 percent upside from IBM's prior close.

The Barclays initiation arrives as the 11th or 12th major positive catalyst to hit IBM in a single month and as the first fresh analyst initiation since the stock's May run that formally acknowledges the new price level as reasonable rather than stretched.

The $1 Billion Quantum Grant That Started Everything

The catalyst that launched IBM's extraordinary May rally arrived on May 21, 2026, when the US Commerce Department announced a $2 billion quantum computing support package distributed among nine companies.

IBM received approximately $1 billion, half the total package, to build what the administration is calling Anderon, a 300-millimeter quantum wafer foundry at IBM's campus in Albany, New York.

The structure of the deal is specific and significant beyond the grant amount itself. IBM will match the federal government's $1 billion with $1 billion of its own money, bringing the total investment in the Anderon foundry to $2 billion.

The US government will take a minority equity stake in IBM in connection with the investment, a feature of the CHIPS Act funding structure that aligns government interests with IBM's commercial success in a way that conventional grants do not.

The Anderon foundry represents IBM's most committed physical investment in quantum computing hardware manufacturing in the company's history. IBM has been a quantum computing pioneer since it first made quantum computers available to researchers over the cloud in 2016.

It has deployed more than 90 quantum systems to more than 325 partner organizations worldwide. The systems it has deployed so far are useful for research and early commercial exploration.

The fault-tolerant quantum computer that IBM is targeting by 2029 is the system that would make quantum commercially transformative, capable of solving problems that classical computers cannot solve within any practical timeframe.

The $2 billion Anderon foundry, combined with IBM's commitment to spend more than $10 billion on quantum over the next five years, gives the 2029 fault-tolerant target a price tag and a production facility that previous quantum roadmaps lacked.

Investors have historically been willing to discount IBM's quantum ambitions as research-era positioning rather than commercial-era commitment. The Albany foundry and the $10 billion investment plan make that dismissal harder to sustain.

Project Lightwell And The AI Open-Source Bet

Alongside the quantum announcements, IBM disclosed that it would invest $5 billion in a project called Lightwell, an AI-driven effort conducted with Red Hat to build and secure open-source software at scale for large enterprises and global financial institutions.

The open-source software security problem that Lightwell is targeting is one of the most significant unresolved vulnerabilities in enterprise technology infrastructure. Open-source code underlies a majority of the software that enterprises run, their databases, their web servers, their application frameworks, their development tools.

The software is free and widely used, but it is also maintained by communities of contributors rather than by companies with commercial liability for security failures. When vulnerabilities appear in widely used open-source packages, as has happened repeatedly over the past decade, the exposure runs through every enterprise that depends on that code.

IBM and Red Hat's Project Lightwell is a commercial subscription model for secure, AI-monitored open-source software, giving enterprises the open-source flexibility they depend on while providing the security guarantees and liability coverage that their regulators and risk officers require.

The $5 billion investment targets the specific intersection of AI capability and enterprise security need that IBM has been positioning toward since its 2019 acquisition of Red Hat for $34 billion.

The Barclays Thesis And Why Software Is The Real Story

The Barclays initiation at Overweight with a $350 target is notable not primarily for the specific price target but for the analytical framework that justifies it. Lenschow's thesis begins with an observation that IBM's own investor communications have been making for several years but that the market has been slow to fully price.

IBM is fundamentally a software company that happens to also have consulting, infrastructure and financing businesses.

Software generates nearly half of IBM's revenue. It generates the majority of the company's profit. Software margins run significantly higher than consulting or infrastructure margins, and software revenue is more recurring and more predictable than project-based consulting revenue.

As IBM's software segment grows faster than its other segments, which it has been doing consistently, the overall company's margin profile improves and its earnings quality increases.

The customer base that IBM's software serves adds a specific durability to that thesis. IBM infrastructure software runs inside large, highly regulated enterprises, banks, insurance companies, healthcare systems, government agencies.

These are organizations with deep compliance requirements, extensive regulatory oversight and a specific aversion to the operational disruption that switching core software creates.

The stickiness of IBM's enterprise software customer base provides a level of revenue predictability that most software companies cannot claim.

Lenschow's assessment that AI is unlikely to significantly disrupt that base is a direct response to the concern that large language models and AI-native software will eat traditional enterprise software revenues.

IBM's software is embedded in mainframe and hybrid cloud workflows that AI might augment but is unlikely to replace, precisely because the regulatory and compliance requirements of IBM's customers make rapid architectural change the riskier option compared to evolution.

The Best Month In 24 Years And What It Says

IBM's approximately 30 percent May gain is the best monthly performance the stock has posted since 2002.

That benchmark is worth examining. 2002 was the year after the September 11 attacks, a period of extraordinary market volatility during which individual stocks could move dramatically based on sentiment rather than fundamentals.

The fact that May 2026 produced a comparable monthly performance reflects a genuine repricing of IBM's business outlook rather than speculative volatility.

The repricing has been driven by hard numbers: a $1 billion federal grant, a $10 billion internal investment commitment, a $2 billion foundry backed by government equity, a $5 billion AI software initiative.

The quantum roadmap went from a research aspiration to a construction project. The AI software bet went from a consulting-era initiative to a platform investment with Red Hat infrastructure behind it.

Wedbush's Dan Ives reiterated an Outperform rating with a $320 target on May 29, naming IBM one of his top software picks as enterprise AI adoption accelerates, a characterization that would have seemed unusual a year ago when IBM was primarily discussed as a legacy infrastructure company facing secular decline.

The $320 Ives target has already been exceeded. Barclays' $350 is the new high-end benchmark from a fresh set of eyes that have studied the updated business case from scratch.